Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) General Information

Description

Rights to the proprietary formulation of a medical product. It consists of proprietary formulation of budesonide for the treatment of various inflammatory and allergic conditions of the eye. Budesonide is provided for the treatment of asthma.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
Primary Office
  • Italy
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide )‘s full profile, request access.

Request a free trial

Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide )‘s full profile, request access.

Request a free trial